Sponsor Pipeline

Foresee Pharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06475781 Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward) Group 3 Pulmonary Hypertension Recruiting
NCT07191535 Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) Asthma (Diagnosis) Not Yet Recruiting
Disease Areas
Hypertension (1) Asthma (1)
Get alerts when Foresee Pharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free